NASDAQ: ORKA
Oruka Therapeutics Inc Stock Ownership - Who owns Oruka Therapeutics?

Insider buying vs selling

Have Oruka Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fairmount Funds Management LLCDirector2024-09-11275,000$23.00
$6.33MBuy
Janus Henderson Group PLC10% Owner2024-08-165,390$2.93
$15.79kBuy
Janus Henderson Group PLC10% Owner2024-08-16428$2.98
$1.27kBuy
Janus Henderson Group PLC10% Owner2024-07-2530,227$3.05
$92.28kBuy
Janus Henderson Group PLC10% Owner2024-07-24165,000$3.20
$528.00kBuy
Janus Henderson Group PLC10% Owner2024-07-247,056$3.16
$22.28kBuy
Janus Henderson Group PLC10% Owner2024-07-2417,800$3.18
$56.59kBuy
Janus Henderson Group PLC10% Owner2024-07-1194,537$3.45
$326.34kBuy
Janus Henderson Group PLC10% Owner2024-07-1033,500$3.47
$116.08kBuy
Janus Henderson Group PLC10% Owner2024-07-1021,963$3.46
$76.06kBuy

1 of 2

ORKA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORKA insiders and whales buy or sell their stock.

ORKA Shareholders

What type of owners hold Oruka Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Harry R. Weller29.21%10,221,465$114.28MInsider
Peter J. Barris29.21%10,221,465$114.28MInsider
Forest Baskett29.21%10,221,465$114.28MInsider
Anthony A. Florence Jr.29.21%10,221,465$114.28MInsider
Krishna Kittu Kolluri29.21%10,221,465$114.28MInsider
Joshua Makower29.21%10,221,465$114.28MInsider
David M. Mott29.21%10,221,465$114.28MInsider
Jon Sakoda29.21%10,221,465$114.28MInsider
Scott D. Sandell29.21%10,221,465$114.28MInsider
Peter W. Sonsini29.21%10,221,465$114.28MInsider

1 of 3

ORKA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORKA10.50%89.50%Net Buying
CMRX25.75%32.10%Net SellingNet Selling
PHAT60.44%39.56%Net SellingNet Selling
ALDX34.53%33.79%Net Buying
ATAI4.39%37.44%Net Selling

Oruka Therapeutics Stock Ownership FAQ

Who owns Oruka Therapeutics?

Oruka Therapeutics (NASDAQ: ORKA) is owned by 49.96% institutional shareholders, 425.82% Oruka Therapeutics insiders, and 0.00% retail investors. Harry R. Weller is the largest individual Oruka Therapeutics shareholder, owning 10.22M shares representing 29.21% of the company. Harry R. Weller's Oruka Therapeutics shares are currently valued at $114.28M.

If you're new to stock investing, here's how to buy Oruka Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.